Evidence map›Paper›PMID 34095444›Full record

ArticleInternational journal of cardiology. Heart & vasculature2020

Application of a machine learning algorithm for detection of atrial fibrillation in secondary care.

Kevin G Pollock, Sara Sekelj, Ellie Johnston, Belinda Sandler, Nathan R Hill, Fu Siong Ng, Sadia Khan, Ayman Nassar, Usman Farooqui

Open access · goldAbstract read
In one paragraph

Article in International journal of cardiology. Heart & vasculature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Is machine learning the future for atrial fibrillation screening?Cardiovascular digital health journal · 2022
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kevin G PollockBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, UK.
Sara SekeljImperial College Health Partners, 30 Euston Square, London NW1 2FB, UK.
Ellie JohnstonImperial College Health Partners, 30 Euston Square, London NW1 2FB, UK.
Belinda SandlerBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, UK.
Nathan R HillBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, UK.
Fu Siong NgChelsea & Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
Sadia KhanChelsea & Westminster Hospital NHS Foundation Trust, 369 Fulham Road, London SW10 9NH, UK.
Ayman NassarBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, UK.
Usman FarooquiBristol-Myers Squibb Pharmaceuticals Ltd, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, UK.
Bristol-Myers Squibb (United Kingdom) · GBChelsea and Westminster Hospital NHS Foundation Trust · GBKings Health Partners · GB

Funding

British Heart Foundation RG/16/3/32175Medical Research Council MC_PC_19007
6 · The paper itself

Abstract

Atrial fibrillation (AF) is the most common sustained heart arrhythmia and significantly increases risk of stroke. Opportunistic AF testing in high-risk patients typically requires frequent electrocardiogram tests to capture the arrhythmia. Risk-prediction algorithms may help to more accurately identify people with undiagnosed AF and machine learning (ML) may aid in the diagnosis of AF. Here, we applied an AF-risk prediction algorithm to secondary care data linked to primary care data in the DISCOVER database in order to evaluate changes in model performance, and identify patients not previously detected in primary care. We identified an additional 5,444 patients who had an AF diagnosis only in secondary care during the data extraction period. 2,696 (49.5%) were accepted by the algorithm and the algorithm correctly assigned 2,637 (97.8%) patients to the AF cohort. Using a risk threshold of 7.4% in patients aged ≥ 30 years, algorithm sensitivity and specificity was 38% and 95%, respectively. Approximately 15% of AF patients assigned to the AF cohort by the algorithm had a secondary care diagnosis with no record of AF in primary care. These additional patients did not substantially alter algorithm performance. The additional detection of previously undiagnosed AF patients in secondary care highlights unexpected potential utility of this ML algorithm.

Indexed as

Artificial intelligenceAtrial fibrillationDiagnosisMachine learning

Identifiers

PMID34095444
PMCPMC8164133
OpenAlexW3107771572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.